9-bromo-N-[2,4-bis(methylthio)-6-methyl-pyridin-3-yl]nonanamide | 225942-12-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 9-bromo-N-[2,4-bis(methylthio)-6-methyl-pyridin-3-yl]nonanamide
• 英文别名: 9-bromo-N-[2,4-bis(methylthio)-6-methyl-3-pyridyl]nonanamide；9-bromo-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]nonanamide
• CAS: 225942-12-1
• 化学式: C₁₇H₂₇BrN₂OS₂
• 分子量: 419.45
• InChiKey: PYOUPUXXPJUPBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  23
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  92.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-mercaptobenzo[d]oxazole-7-carboxylate 、 9-bromo-N-[2,4-bis(methylthio)-6-methyl-pyridin-3-yl]nonanamide 在 18-冠醚-6 potassium carbonate 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 4.0h， 以72%的产率得到9-(7-methoxycarbonylbenzoxazol-2-ylthio)-N-[2,4-bis(methylthio)-6-methyl-pyridin-3-yl]nonanamide
  参考文献：
  名称：

  Amide compounds and medications containing the same technical field

  摘要：

  本发明提供了一种具有ACAT抑制活性的新型化合物。本发明涉及由式(I)表示的化合物，其中表示一个可选择取代的二价残基，如苯、吡啶、环己烷或萘，或一个基团，Het表示一个含有来自氮原子、氧原子和硫原子的异原子中至少一个的5-至8-成员取代或未取代的杂环基，例如单环基、多环基或融合环的基团，X表示—NH—、一个氧原子或一个硫原子，Y表示—NR4—、一个氧原子、一个硫原子、一个亚氧化物或一个砜，Z表示一个单键或—NR5—，R4表示氢原子、低碳基团、芳基或一个可选择取代的硅基低碳基团，R5表示氢原子、低碳基团、芳基或一个可选择取代的硅基低碳基团，n为1至15的整数，或其盐或溶剂合物，以及含有这些化合物之一的药物组合物。

  公开号：

  US06849647B1

文献信息

• Novel amide compounds and medications containing the same
  申请人：Shibuya Kimiyuki

  公开号：US20050131002A1

  公开（公告）日：2005-06-16

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR 4 —, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR 5 —, R 4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R 5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有ACAT抑制活性的新化合物。本发明涉及由式(I)表示的化合物，其中表示一种可选取代的二价残基，例如苯，吡啶，环己烷或萘，或者一个基团，Het表示一种5-至8-成员的取代或未取代的杂环基团，其中至少包含从氮原子，氧原子和硫原子中选取的一种杂原子，例如单环基团，多环基团或融合环的基团，X表示-NH-，氧原子或硫原子，Y表示-NR4-，氧原子，硫原子，亚砜或磺酰基，Z表示单键或-NR5-，R4表示氢原子，低碳基，芳基或可选取代的硅烷低碳基，R5表示氢原子，低碳基，芳基或可选取代的硅烷低碳基，n为1到15的整数，或其盐或溶剂，以及含有这些化合物中至少一种的药物组合物。
• Novel amide compounds and medications containing the same technical field
  申请人：Shibuya Kimiyuki

  公开号：US20050131001A1

  公开（公告）日：2005-06-16

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR 4 —, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR 5 —, R 4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R 5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有ACAT抑制活性的新化合物。本发明涉及由式(I)表示的化合物，其中表示可选取代的二价残基，例如苯，吡啶，环己烷或萘，或基团，Het表示包含至少一种异原子（从氮原子，氧原子和硫原子中选择）的5-至8-成员取代或未取代的杂环基团，例如单环基团，多环基团或融合环基团，X表示-NH-，氧原子或硫原子，Y表示-NR4-，氧原子，硫原子，亚砜或磺酰基，Z表示单键或-NR5-，R4表示氢原子，低碳基，芳基或可选取代的硅基低碳基，R5表示氢原子，低碳基，芳基或可选取代的硅基低碳基，n为1至15的整数，或其盐或溶剂，以及含有这些化合物中至少一种的药物组合物。
• Amide compounds and medications containing the same
  申请人：Kowa Company, Ltd.

  公开号：US07393866B2

  公开（公告）日：2008-07-01

  The present invention provides to a novel compound having an ACAT inhibiting activity. The present invention relates to compounds represented by formula (I) wherein represents an optionally substituted divalent residue such as benzene, pyridine, cyclohexane or naphthalene, or a group, Het represents a 5- to 8-membered, substituted or unsubstituted heterocyclic group containing at least one heteroatom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, such as a monocyclic group, a polycyclic group or a group of a fused ring, X represents —NH—, an oxygen atom or a sulfur atom, Y represents —NR4—, an oxygen atom, a sulfur atom, a sulfoxide or a sulfone, Z represents a single bond or —NR5—, R4 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, R5 represents a hydrogen atom, a lower alkyl group, an aryl group or an optionally substituted silyl lower alkyl group, and n is an integer of from 1 to 15, or salts or solvates thereof, and a pharmaceutical composition containing at least one of these compounds.

  本发明提供了一种具有ACAT抑制活性的新型化合物。本发明涉及由式（I）表示的化合物，其中表示可选取代的二价残基，例如苯、吡啶、环己烷或萘，或者是一个杂环基团，该杂环基团是一个含有至少一个氮原子、一个氧原子和一个硫原子的杂原子的5-至8-成员取代或未取代的杂环基团，例如单环基团、多环基团或融合环的基团，X表示—NH—、一个氧原子或一个硫原子，Y表示—NR4—、一个氧原子、一个硫原子、一个亚砜或一个磺酰基，Z表示一个单键或—NR5—，R4表示氢原子、低碳基、芳基或可选取代的硅基低碳基，R5表示氢原子、低碳基、芳基或可选取代的硅基低碳基，n为1至15的整数，或其盐或溶剂合物，以及包含这些化合物中至少一种的制药组合物。
• NOVEL AMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME
  申请人：Kowa Company Ltd.

  公开号：EP0979823B1

  公开（公告）日：2006-03-29
• US6849647B1
  申请人：——

  公开号：US6849647B1

  公开（公告）日：2005-02-01